The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
At-Home Drug of Abuse (DOA) Testing-Global Market Insights and Sales Trends 2024
Synopsis
The at-home DOA testing market has been categorized into rapid DOA test kits and breath analyzers.
The global At-Home Drug of Abuse (DOA) Testing market size is expected to reach US$ 862.3 million by 2029, growing at a CAGR of 10.6% from 2023 to 2029. The market is mainly driven by the significant applications of At-Home Drug of Abuse (DOA) Testing in various end use industries. The expanding demands from the Urine, Saliva, Hair and Others, are propelling At-Home Drug of Abuse (DOA) Testing market. Test Cups, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Test Dip Cards segment is estimated at % CAGR for the next seven-year period.
The market is mainly driven by the increased production and trade of illicit drugs worldwide, growing use of illicit drugs amongst teenagers, and initiatives by government organizations to reduce the level of drug abuse.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for At-Home Drug of Abuse (DOA) Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global At-Home Drug of Abuse (DOA) Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global At-Home Drug of Abuse (DOA) Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, At-Home Drug of Abuse (DOA) Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of At-Home Drug of Abuse (DOA) Testing covered in this report include UCP Biosciences, Orient New Life Medical, Express Diagnostics Int’l, Assure Tech (Hangzhou), Psychemedics Corporation, Confirm BioSciences, Phamatech, Home Health (U.K.) Ltd. and Quest Products, etc.
The global At-Home Drug of Abuse (DOA) Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
UCP Biosciences
Orient New Life Medical
Express Diagnostics Int’l
Assure Tech (Hangzhou)
Psychemedics Corporation
Confirm BioSciences
Phamatech
Home Health (U.K.) Ltd.
Quest Products
Global At-Home Drug of Abuse (DOA) Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global At-Home Drug of Abuse (DOA) Testing market, Segment by Type:
Test Cups
Test Dip Cards
Test Strips
Others
Global At-Home Drug of Abuse (DOA) Testing market, by Application
Urine
Saliva
Hair
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of At-Home Drug of Abuse (DOA) Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The at-home DOA testing market has been categorized into rapid DOA test kits and breath analyzers.
The global At-Home Drug of Abuse (DOA) Testing market size is expected to reach US$ 862.3 million by 2029, growing at a CAGR of 10.6% from 2023 to 2029. The market is mainly driven by the significant applications of At-Home Drug of Abuse (DOA) Testing in various end use industries. The expanding demands from the Urine, Saliva, Hair and Others, are propelling At-Home Drug of Abuse (DOA) Testing market. Test Cups, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Test Dip Cards segment is estimated at % CAGR for the next seven-year period.
The market is mainly driven by the increased production and trade of illicit drugs worldwide, growing use of illicit drugs amongst teenagers, and initiatives by government organizations to reduce the level of drug abuse.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for At-Home Drug of Abuse (DOA) Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global At-Home Drug of Abuse (DOA) Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global At-Home Drug of Abuse (DOA) Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, At-Home Drug of Abuse (DOA) Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of At-Home Drug of Abuse (DOA) Testing covered in this report include UCP Biosciences, Orient New Life Medical, Express Diagnostics Int’l, Assure Tech (Hangzhou), Psychemedics Corporation, Confirm BioSciences, Phamatech, Home Health (U.K.) Ltd. and Quest Products, etc.
The global At-Home Drug of Abuse (DOA) Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
UCP Biosciences
Orient New Life Medical
Express Diagnostics Int’l
Assure Tech (Hangzhou)
Psychemedics Corporation
Confirm BioSciences
Phamatech
Home Health (U.K.) Ltd.
Quest Products
Global At-Home Drug of Abuse (DOA) Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global At-Home Drug of Abuse (DOA) Testing market, Segment by Type:
Test Cups
Test Dip Cards
Test Strips
Others
Global At-Home Drug of Abuse (DOA) Testing market, by Application
Urine
Saliva
Hair
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of At-Home Drug of Abuse (DOA) Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of At-Home Drug of Abuse (DOA) Testing
1.1 At-Home Drug of Abuse (DOA) Testing Market Overview
1.1.1 At-Home Drug of Abuse (DOA) Testing Product Scope
1.1.2 At-Home Drug of Abuse (DOA) Testing Market Status and Outlook
1.2 Global At-Home Drug of Abuse (DOA) Testing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global At-Home Drug of Abuse (DOA) Testing Market Size by Region (2018-2029)
1.4 Global At-Home Drug of Abuse (DOA) Testing Historic Market Size by Region (2018-2023)
1.5 Global At-Home Drug of Abuse (DOA) Testing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, At-Home Drug of Abuse (DOA) Testing Market Size (2018-2029)
1.6.1 North America At-Home Drug of Abuse (DOA) Testing Market Size (2018-2029)
1.6.2 Europe At-Home Drug of Abuse (DOA) Testing Market Size (2018-2029)
1.6.3 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size (2018-2029)
1.6.4 Latin America At-Home Drug of Abuse (DOA) Testing Market Size (2018-2029)
1.6.5 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size (2018-2029)
2 At-Home Drug of Abuse (DOA) Testing Market by Type
2.1 Introduction
2.1.1 Test Cups
2.1.2 Test Dip Cards
2.1.3 Test Strips
2.1.4 Others
2.2 Global At-Home Drug of Abuse (DOA) Testing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global At-Home Drug of Abuse (DOA) Testing Historic Market Size by Type (2018-2023)
2.2.2 Global At-Home Drug of Abuse (DOA) Testing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America At-Home Drug of Abuse (DOA) Testing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe At-Home Drug of Abuse (DOA) Testing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America At-Home Drug of Abuse (DOA) Testing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa At-Home Drug of Abuse (DOA) Testing Revenue Breakdown by Type (2018-2029)
3 At-Home Drug of Abuse (DOA) Testing Market Overview by Application
3.1 Introduction
3.1.1 Urine
3.1.2 Saliva
3.1.3 Hair
3.1.4 Others
3.2 Global At-Home Drug of Abuse (DOA) Testing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global At-Home Drug of Abuse (DOA) Testing Historic Market Size by Application (2018-2023)
3.2.2 Global At-Home Drug of Abuse (DOA) Testing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America At-Home Drug of Abuse (DOA) Testing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe At-Home Drug of Abuse (DOA) Testing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America At-Home Drug of Abuse (DOA) Testing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa At-Home Drug of Abuse (DOA) Testing Revenue Breakdown by Application (2018-2029)
4 At-Home Drug of Abuse (DOA) Testing Competition Analysis by Players
4.1 Global At-Home Drug of Abuse (DOA) Testing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in At-Home Drug of Abuse (DOA) Testing as of 2022)
4.3 Date of Key Players Enter into At-Home Drug of Abuse (DOA) Testing Market
4.4 Global Top Players At-Home Drug of Abuse (DOA) Testing Headquarters and Area Served
4.5 Key Players At-Home Drug of Abuse (DOA) Testing Product Solution and Service
4.6 Competitive Status
4.6.1 At-Home Drug of Abuse (DOA) Testing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 UCP Biosciences
5.1.1 UCP Biosciences Profile
5.1.2 UCP Biosciences Main Business
5.1.3 UCP Biosciences At-Home Drug of Abuse (DOA) Testing Products, Services and Solutions
5.1.4 UCP Biosciences At-Home Drug of Abuse (DOA) Testing Revenue (US$ Million) & (2018-2023)
5.1.5 UCP Biosciences Recent Developments
5.2 Orient New Life Medical
5.2.1 Orient New Life Medical Profile
5.2.2 Orient New Life Medical Main Business
5.2.3 Orient New Life Medical At-Home Drug of Abuse (DOA) Testing Products, Services and Solutions
5.2.4 Orient New Life Medical At-Home Drug of Abuse (DOA) Testing Revenue (US$ Million) & (2018-2023)
5.2.5 Orient New Life Medical Recent Developments
5.3 Express Diagnostics Int’l
5.3.1 Express Diagnostics Int’l Profile
5.3.2 Express Diagnostics Int’l Main Business
5.3.3 Express Diagnostics Int’l At-Home Drug of Abuse (DOA) Testing Products, Services and Solutions
5.3.4 Express Diagnostics Int’l At-Home Drug of Abuse (DOA) Testing Revenue (US$ Million) & (2018-2023)
5.3.5 Assure Tech (Hangzhou) Recent Developments
5.4 Assure Tech (Hangzhou)
5.4.1 Assure Tech (Hangzhou) Profile
5.4.2 Assure Tech (Hangzhou) Main Business
5.4.3 Assure Tech (Hangzhou) At-Home Drug of Abuse (DOA) Testing Products, Services and Solutions
5.4.4 Assure Tech (Hangzhou) At-Home Drug of Abuse (DOA) Testing Revenue (US$ Million) & (2018-2023)
5.4.5 Assure Tech (Hangzhou) Recent Developments
5.5 Psychemedics Corporation
5.5.1 Psychemedics Corporation Profile
5.5.2 Psychemedics Corporation Main Business
5.5.3 Psychemedics Corporation At-Home Drug of Abuse (DOA) Testing Products, Services and Solutions
5.5.4 Psychemedics Corporation At-Home Drug of Abuse (DOA) Testing Revenue (US$ Million) & (2018-2023)
5.5.5 Psychemedics Corporation Recent Developments
5.6 Confirm BioSciences
5.6.1 Confirm BioSciences Profile
5.6.2 Confirm BioSciences Main Business
5.6.3 Confirm BioSciences At-Home Drug of Abuse (DOA) Testing Products, Services and Solutions
5.6.4 Confirm BioSciences At-Home Drug of Abuse (DOA) Testing Revenue (US$ Million) & (2018-2023)
5.6.5 Confirm BioSciences Recent Developments
5.7 Phamatech
5.7.1 Phamatech Profile
5.7.2 Phamatech Main Business
5.7.3 Phamatech At-Home Drug of Abuse (DOA) Testing Products, Services and Solutions
5.7.4 Phamatech At-Home Drug of Abuse (DOA) Testing Revenue (US$ Million) & (2018-2023)
5.7.5 Phamatech Recent Developments
5.8 Home Health (U.K.) Ltd.
5.8.1 Home Health (U.K.) Ltd. Profile
5.8.2 Home Health (U.K.) Ltd. Main Business
5.8.3 Home Health (U.K.) Ltd. At-Home Drug of Abuse (DOA) Testing Products, Services and Solutions
5.8.4 Home Health (U.K.) Ltd. At-Home Drug of Abuse (DOA) Testing Revenue (US$ Million) & (2018-2023)
5.8.5 Home Health (U.K.) Ltd. Recent Developments
5.9 Quest Products
5.9.1 Quest Products Profile
5.9.2 Quest Products Main Business
5.9.3 Quest Products At-Home Drug of Abuse (DOA) Testing Products, Services and Solutions
5.9.4 Quest Products At-Home Drug of Abuse (DOA) Testing Revenue (US$ Million) & (2018-2023)
5.9.5 Quest Products Recent Developments
6 North America
6.1 North America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 At-Home Drug of Abuse (DOA) Testing Market Dynamics
11.1 At-Home Drug of Abuse (DOA) Testing Industry Trends
11.2 At-Home Drug of Abuse (DOA) Testing Market Drivers
11.3 At-Home Drug of Abuse (DOA) Testing Market Challenges
11.4 At-Home Drug of Abuse (DOA) Testing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
